Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Elan Prialt NDA Amendment Puts Drug On Schedule For Early 2005 Launch

Jun 29 2004

• By Mary Jo Laffler

Related Content

Pain R&amp;D Firms Target Nerve Cell Signaling In Hunt For Potent Non-Opioids

Feb 02 2004

Antegren BLA Submission For Multiple Sclerosis Could See Approval By Year-End

May 25 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window